TED Ted Baker Plc

RNS Number:1933F
Tepnel Life Sciences PLC
05 October 2007



              Tepnel Life Sciences plc ('Tepnel' or 'the Company')


                                Grant of options


Manchester, U.K, 5 October 2007 Tepnel Life Sciences plc (AIM: TED), the
international Molecular Diagnostics and Research Products & Services group,
today announces that it has granted, in aggregate, 5,800,000 share awards to
certain employees (but not directors) of the Company under the Tepnel Life
Sciences plc 2006 Long Term Incentive Plan ("Long Term Incentive Plan"). The
Long Term Incentive Plan was introduced by Tepnel in August 2006 to align more
closely management incentives with the interests of shareholders by linking the
award to growth in the Company's share price over the 3 year vesting period.

The 5,800,000 nil cost options granted will be released based on the growth in
the Company's share price over the period from the date of grant to the third
anniversary of the date of grant in accordance with the following table:

+-----------------------------------+-----------------------------------+
|        Share Price Target         |        % of Award Released        |
+-----------------------------------+-----------------------------------+
|               14.5p               |                25%                |
+-----------------------------------+-----------------------------------+
|               16.9p               |               100%                |
+-----------------------------------+-----------------------------------+
Straight line vesting between points

No awards will be released unless the return of a Company's share exceeds the
return on the FTSE AIM Index over the same period.

                                     -End-

For further information:

Tepnel Life Sciences plc
Ben Matzilevich, CEO
Carol Smith
Tel: 0161 946 2200

Capital MS&L
Mary Clark or Catie Corcoran
Tel: +44 20 7307 5330

Seymour Pierce Limited
Mark Percy
Tel: +44 20 7107 8000



Notes to Editors:
About Tepnel Life Sciences plc

Tepnel Life Sciences plc (AIM: TED) is a UK-based international life sciences
products and services group with two divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with 195 employees.

Tepnel provides test kits, reagents and services to two highly synergistic
markets, these being Molecular Diagnostics and Biomedical Research.

The Company's strategy has been to identify high growth niche opportunities
within these multi-billion pound markets. Tepnel focuses on these opportunities
with internally developed products, patents, expertise and know-how as well as
strategic acquisitions, to develop a leadership position within these defined
market segments.





                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCBRBDGUDGGGRS

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024